The 3-month readmission rate remains unacceptably high in a large North American cohort of patients with cirrhosis

North American Consortium for the Study of End-Stage Liver Disease

Research output: Contribution to journalArticle

107 Scopus citations

Fingerprint Dive into the research topics of 'The 3-month readmission rate remains unacceptably high in a large North American cohort of patients with cirrhosis'. Together they form a unique fingerprint.

Medicine & Life Sciences